BP therapy affects dental implant surgery

0
2362
BP therapy
Copyright: eldarnurkovic / 123RF Stock Photo

BP therapy to prevent bone loss in postmenopausal woman has been shown to affect dental implant surgery, new research from Japan—and published recently in the Journal of Oral Implantology—has found.

Postmenopausal women often suffer from osteoporosis, resulting in a loss of bone mass and strength. To combat this disease, many women take bisphosphonates (BPs), a group of medicines that help slow or prevent bone loss. However, BP therapy in terms of successful dental implantation has not been well documented.

Dental implantation tends to be highly predicative in terms of effectiveness, but when medication is introduced that will change the overall landscape of the mandible (jawbone) structure, implant failure can be a side effect.

To study the use of BP therapy and its effect on the quality of the jawbone, a team from the Kanagawa Dental University Hospital and the Tokyo Medical and Dental University evaluated the bone mineral density and the outer layer bone thickness of the jawbone in 25 female patients, as well as how long-term BP therapy affected early implant failure.

First, the researchers divided their study subjects—who were at least 60 years of age, with a previous osteoporosis diagnosis, and who had undergone dental implant surgery in the jawbone between January 2010 and March 2013—into two groups: a BP group consisting of 11 patients who had been taking BPs for more than one year, and a non-BP group consisting of 14 patients who had been prescribed a type of hormone therapy.

They then compared both groups using several CT scans of their mandible to gauge bone mineral densities, cortical bone thickness, and the effect that the duration of BP therapy had on these two factors.

The researchers found that in the BP group, 11 patients with a total of 25 implants had three of those implants fail in three different patients within one year. In the non-BP group, the 14 patients had a total of 28 implants. Every implant in the non-BP group survived.

It was also found that the BP group had a higher bone mineral density than the non-BP group, and those patients with a longer duration of BP therapy had increased cortical bone thickness.

Overall, the researchers concluded that BP use is correlated with increased bone mineral density and cortical bone thickness.

Previous articleUQ dentistry experts to lead ADAQ
Next articleOffice-based dental anaesthesia gaining ground over hospital-based

LEAVE A REPLY

Please enter your comment!
Please enter your name here